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Abstract
Erythromelalgia is a rare and very difficult to treat pain 
syndrome that usually presents as severe bilateral burning 
pain in the extremities. Here we present a case of a 34-year-
old female with erythromelalgia who we treated successfully 
with a lumbar epidural infusion of ropivacaine and fentanyl. 
The patient had complete relief shortly after the epidural 
infusion, and she remained stable with only minor pain 
two weeks and nine months later. With this case, we have 
reviewed the interventional treatments of erythromelalgia. 
We suggest epidural infusion as the first line interventional 
management, followed by sympathetic block. Spinal 
cord stimulation can be considered if other interventional 
managements fail.
ro-humoral changes, particularly in distal limbs. Here 
we present a case of erythromelalgia successfully treat-
ed with a lumbar epidural of Ropivacaine/Fentanyl infu-
sion. We also review current interventional treatments 
for erythromelalgia.
Case Presentation
IRB approval was exempted from University of Cali-
fornia San Francisco for this case report of patient treat-
ment. A 34-year-old woman with a history of chronic 
constipation, recent episode of C. difficile colitis, and 
presumed alcoholic peripheral neuropathy presented 
to our medical center with severe burning pain in her 
feet after an exhaustive workup at an outside hospital. 
The pain was so severe that no medication was effec-
tive, including opioids, neuroleptics, and nonsteroidal 
anti-inflammatories (NSAIDs), and the only manage-
ment that gave her pain relief was soaking her feet in 
ice baths. The pain was worse at night, but stayed at 
substantial severity during the daytime. She submerged 
her feet in ice water for 8-10 hours a day for pain relief, 
and she placed hot packs on her thighs to offset the cold 
discomfort from the ice-baths. On exam her feet were 
brightly erythematous and warm to touch bilaterally. 
Numerous ulcers were present on the dorsum of the 
feet (Figure 1a, and Figure 1b). She also had secondary 
tissue damage from both the hot packs on her thighs 
and the cold baths, resulting in a livedo reticularis rash 
(Figure 1c). She was evaluated by multiple specialists in 
our hospital, including neurology, vascular surgery, hos-
pital medicine, and dermatology services, before the 
pain service was consulted. She had an extensive work-
up that included infectious, metabolic, rheumatologic, 
neurologic systems, with extensive imaging studies (Ta-
ble 1). An electromyography (EMG) study showed an ax-
onal neuropathy pattern. She was undergoing thiamine 
and folate supplementation with the thought that her 
pain might be related to alcohol consumption (she had 
periods of heavy binge drinking over the past 3 years, 
although none in the past 2 months). 
Given her classic presentation for erythromelalgia, 
the pain service started the full dose of aspirin because 
Introduction
Erythromelalgia is a rare pain syndrome character-
ized by a bilateral burning sensation in the extremities 
that is often aggravated by physical activity or heat. 
The incidence is estimated as 1.3 per 100,000 people 
[1]. Erythromelalgia is very difficult to treat, with only 
a few reported cases of complete resolution. Common-
ly, patients resort to soaking the affected extremities in 
ice water as the only effective mediator of their pain. 
This prolonged exposure of the painful extremities to 
ice water can produce secondary damage caused by the 
reduced circulation from the low temperature.
Erythromelalgia is classified as either primary that 
occurs sporadically or is inherited, or secondary that is 
related to various autoimmune and myeloproliferative 
disorders. The etiology has remained elusive until the 
mapping of a familial form of erythromelalgia in the 
SNA9a gene, which encodes the Na
v
1.7 sodium channel 
as a gain-of-function mutation resulting in hyper-excit-
ability in dorsal root ganglion (DRG) sensory neurons 
[2]. Further investigation of other familial erythromelal-
gia lineages has resulted in more than a dozen similar 
gain of function mutations of Na
v
1.7 sodium channel [2-
4]. All these mutations act to enhance the excitability 
of DRG neurons by lowering the firing threshold. It has 
been hypothesized that given the similar phenotype, 
the non-genetic forms of erythromelalgia may be relat-
ed to DRG neuronal hyper-excitability leading to neu-
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significant subpopulation of erythromelalgia patients 
are responsive to aspirin [5]. However, she was unre-
sponsive to aspirin and still reported her pain as 10/10. 
We subsequently placed a lumbar epidural and ran a 
continuous infusion of 0.0625% ropivacaine with 2 mcg/
ml fentanyl at 12 ml/hour. Her pain score decreased to 
0-1/10 almost immediately after the initiation of epidur-
al infusion. We continued the epidural infusion over the 
next three days. The patient’s motor function was pre-
served and she was able to participate in physical ther-
apy. On day four of epidural infusion we slowly weaned 
off the infusion, and the patient’s pain remained at 
1-2/10 after the epidural infusion was discontinued. 
Physical examination showed that her feet were no 
longer brightly erythematous, but now were darkened 
with pigmentation. The feet were normothermic, the 
allodynia had been resolved, and the chronic ulcers in 
her feet started to heal with healthy granulation tissue 
noted (Figure 1d and Figure 1f). She was discharged 
home the next day, and the two-week follow-up visit 
in our chronic pain clinic documented that her pain re-
mained at 0-2/10, and her functional status completely 
returned to her baseline. At a phone follow-up at nine 
months, she reported that her pain was still at 0-2/10, 
and she was maintaining her full activities of daily liv-
ing. The CURES (Controlled Substance Utilization Re-
view and Evaluation System) report confirms that she 
has not used any opioid since the treatment of epidural 
infusion.
Discussion
Familial erythromelalgia is caused by mutation of 
sodium channel Na
v
1.7 [2] which leads to this unique 
constellation of symptoms. It is unlikely that our patient 
suffered from this genetic syndrome given her presen-
tation in adulthood. Although we do not know the exact 
pathophysiology behind her symptoms, we postulate it 
was caused by abnormal function of DRG nociceptors 
with possible concomitant sympathetic nervous system 
dysfunction. The treatment with epidural ropivacaine 
served to suppress both pathways, and may have al-
lowed a new homeostasis to occur. In addition, central 
sensitization in spinal cord, which could be inhibited as 
well by the epidural infusion of local anesthetics, might 
have also contributed to her pain syndrome. Whatev-
er the mechanism, this case indicates that a standard 
epidural infusion should be considered as a modality to 
treat erythromelalgia in adults. 
Medical treatment is the first line of therapies for 
 
Figure 1: Skin findings before and after epidural treatment. A,B) Images of patient’s lower extremities at presentation. 
Note the ulcers on her feet from extended soaking in ice-water. C. Thighs have a rash consistent with livedo reticularis from 
heating pads to counteract the pain of soaking feet in ice-water. D-F) Feet show dramatic decrease in erythema with healthy 
granulation tissue forming in bed of ulcers after treatment with epidural.
• Page 93 •Transl Perioper & Pain Med 2019; 6 (4)
DOI: 10.31480/2330-4871/094
Intervention Patient Details Outcome Citation
Epidural 
Infusion
17yo M
72yo F
6yo M
11yo M
28yo F
12yo M & 
17yo M
13yo M
15yo M
Failed medical tx including IV ketamine. LE 
peripheral nerve blocks ineffective. Ulcers 
infected required split thickness skin grafting; 
L3/4 epidural infusion (0.2% ropivacaine 10-
12 ml/hr) -2 weeks
EM and polycythemia vera with Jak2 
mutation; started on alpha2-interferon and 
lumbar epidural infusion with PCEA (0.2% 
ropivacaine, 0.15 Lidocaine and 5 ug/mL 
fentanyl) for pain
Burning in hands > feet, bilateral axillary 
catheters placed- 0.25% bupivacaine 1 wk; 
represented 2 hrs later, sciatic catheters-
placed then dislodged, then epidural catheter 
bupivacaine 0.25%, fentanyl 2 mcg/ml- 6 
weeks of treatment
Trialed on nalbuphine, pentoxifylline, 
nitroprusside in ICU without relief. L4-5 
epidural infusion (0.125% bupivacaine, 5 ug/
mL fentanyl)- 1 wk
New diagnosis after workup as inpatient, 
discharged. L4-5 epidural placed in outpatient 
pain clinic. Bolus of 0.125% bupivacaine (10 
ml)- immediate improvement in pain, catheter 
left in place and patient returned following 
day, catheter was bolused again. On Day 
3 symptoms were stable and catheter was 
removed.
Both with significant upper extremity 
symptoms- cervical epidural (C7-T1) placed 
(bupivacaine 0.125-0.25%) at 5-10 ml/hr (17 
yo pt: 9 days, 12 yo pt:4 days then surgically 
placed epidural used for 37 days)
Upper extremity pain, failed medical therapy 
and immunoglobulin tx, cervical epidural with 
bupivacaine and morphine for 2 wks
L3-4 epidural infusion (0.125% bupivacaine, 
fentanyl 1 ug/ml) 12 ml/hr for 2.5 days
Wounds healed, 6mo 
improvement of erythema and 
edema, discontinued opioids
Pain well controlled acutely, 4 
year follow up mild symptoms
2.5 yr follow up- resolution of 
pain, not taking medications
Acute pain control but long-
term control with oral Mexiletine
1 yr asymptomatic, off 
medication
17 yo pt asymptomatic at 2 yrs. 
12 yo pt asymptomatic after 16 
months
Improved erythema and 
edema. Significant atrophy 
of arms, required weeks of 
physical therapy to regain 
strength
Complete resolution at 1 yr
Lee, 2017
Li, 2016
Harrison, 2003
Nathan, 2005
Stricker, 2001
Rauk, 1996
Mohr, 1994
D’Angelo, 1991
Table 1
may be justified.
In this case we have successfully treated an adult 
erythromelalgia patient with epidural infusion of 
0.0625% ropivacaine with 2 mcg/ml fentanyl at 12 ml/
hour for 3 days, and patient’s pain was well controlled 
even nine months after the treatment. While there are 
a few reported cases of epidural treatment that have 
led to good pain relief in pediatric patients [7-13], to our 
the erythromelalgia. Commonly trialed medications in-
clude aspirin which may be effective in those with con-
current platelet dyscrasias caused by JAK-2 mutations 
[6]. Other commonly trialed medications include cal-
cium channel blockers, sodium channel blockers, anti-
convulsants, NSAIDs, and antidepressants [5]. However, 
many patients do not have a good response to medical 
treatment and invasive procedures for these patients 
• Page 94 •Transl Perioper & Pain Med 2019; 6 (4)
DOI: 10.31480/2330-4871/094
Several invasive techniques have been described 
with varying degrees of success. Broadly they include 
providing sympathetic blockade or targeting central 
nervous system modulation. Peripheral nerve blocks, 
knowledge this is one of a few adult case of erythro-
melalgia patient successfully managed with an epidural 
infusion [10,14].
Sympathetic 
Block
22yo F
70yo F
12yo F
18yo M
59yo M
21yo F
2 M, 1 F
Lumbar sympathetic block- good relief- 
followed by pulse radio frequency tx of LSG
Failed medical txs, bilateral LSG block with 
Ropivacaine 0.375%; 
Failed medical and caudal/epidural 
treatments, Bilateral LSG block with 1% 
lidocaine and triamcinolone
Failed medical treatments, admitted for 
intractable pain, LSG with alcohol
LSG- alcohol ablation was placed after failing 
medical and epidural treatments
Failed medical treatments, bilateral LSG, then 
Spinal block (8 times over 4 months)
10 days of consecutive LSG blocks 
alternative left and right
Improvement in VAS, continued 
on medication
Improvement of pain, healing of 
ulcers after 6 wks
Moderate reduction in pain, 
LSG repeated, reduction in 
erythema, still soaking feet in 
water and waking at night
Two weeks post, discharged 
with improvement in symptoms-
edema, pain, ulcers healing
Immediate relief following 
unilateral, block, contralateral 
block pain relief for 9mo.
Good relief after LSG and 
reduction in symptoms with 
intermittent spinal blocks
At 1 and 3 years, symptoms 
had not recurred
Lee, 2016
Cerci,2013
Bang, 2010
Galemberti,2009
Seishima, 2000
Takeda, 1989
Buoncristiano, 
1985
Spinal Cord 
Stimulator
20yr M
15yo F
80yo F
69yo F
Two SCS generators, two cervical and two 
thoracic leads
T12-L1, two leads 2 V, 10 Hz, and 300-μs 
pulse width
T11 dual lead SCS
T9-10 quad lead SCS
Good pain relief, off all meds, 
return to normal fx
Improvement in pressure 
related pain, feet remain 
erythematous and burning- 
remained on Mexiletine
Good pain relief, dramatic 
reduction in opioids, return of 
functional status
Good relief after replacement of 
faulty generator
Eckman, 2017
Patel, 2015
Matzke, 2016
Graziotta, 1993
Brain 
Stimulation
12yo M Had good relief with SCS which was removed 
for Staph infection twice, near suicidal after 
removal, doctors felt invasive nature was 
warranted . Thalamic electrode placed- 
bilateral ventral posterolateral nuclei (VPL)-  
210 microseconds, 100 Hz, 1.5 V right, and 
2.9 V left
Not suicidal. Able to decrease 
medications and ice bath 
soaking. No change in 
erythema.
Delye, 2005
Thalamic 
nucleus 
ablation
11yo M, 
13yo F, 
15yo M 
Varying degrees of severity of disease. 
Ablation of VPL with/without ablation of 
centromedian nucleus (CM)
Resolution of both pain and 
symptoms. One case, no 
resolution after unilateral 
ablation, but resolution after 
contralateral ablation Soviet 
era- raises ethical questions
Kandel, 1990
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pain by modulating local neurotransmitter levels in the 
dorsal horns [19,20]. Similarly, targeting DRG neurons 
with stimulation has been reported as a treatment of 
erythromelalgia [16].
Even more invasive techniques have been described. 
One example is a 12-year-old with severe erythromelal-
gia symptoms that were leading to suicidality [21]. After 
infections forced the discontinuation of a spinal cord 
stimulation trial twice, bilateral thalamic electrodes 
were placed in the ventral posterolateral nuclei by a 
neurosurgeon. Continuous stimulation achieved im-
provement in pain, ablated suicidality, but had no effect 
on erythema. This invasive approach was inspired by an 
even more invasive approach described by a Soviet-era 
neurosurgeon of three Russian children who achieved 
complete resolution of erythromelalgia symptoms with 
stereotaxic ablation of the ventral posterolateral and 
the centromedian nuclei of the thalamus [22]. This ir-
reversible, invasive, high-risk procedure performed in 
children raises many ethical questions, but may also of-
fer insight into the mechanism of this disorder. 
Erythromelalgia remains a challenging disorder to 
treat. Response to interventions will be highly depen-
dent on the underlying cause of the disorder. Based on 
the risk benefit profile of all of the described invasive 
techniques we recommend pursuing medical ther-
apies first, ideally to be combined with cognitive and 
social support that are known to improve chronic pain 
[23]. An epidural infusion should be considered second 
line as the risks are low and relief can be significant and 
lasting in a variety of cases. If necessary, epidural can 
be done at the bedside without fluoroscopy. If epidural 
infusion does not offer good relief, or if it is not last-
ing, sympathetic blockade should be considered. Local 
anesthetic block of the sympathetic ganglion should 
be trialed to assess for patient response. With a good 
response, neurolysis can be achieved and may offer 
long-lasting relief. Unlike epidural, lumbar sympathet-
ic block requires fluoroscopy and specific procedure 
room. Next, we suggest a trial of spinal cord stimulator 
given the expense and invasive nature of spinal cord 
modulation. Finally, with certain cases, especially those 
with contraindications to spinal cord stimulator, tha-
lamic electrode implantation may be considered. While 
serious risks are associated with thalamic electrode 
implantation, erythromelalgia in some patients can be 
so severe and debilitating the benefits may justify the 
risks. 
As the genetics and pathophysiology of erythrome-
lalgia becomes better understood, targeted therapeu-
tics will be developed which will hopefully improve 
quality of life for these patients. For those who have 
poor response to medications, invasive techniques will 
continue to play a role in threating this disorder.
epidurals and sympathetic plexus blocks have been 
described with success in several cases. Although 
significantly different in technique, invasiveness and 
duration, they all likely act by inhibiting sympathetic 
outflow to the affected limbs. Here we summarize 
the relevant case reports and case series for these 
interventions (Table 1). One hypothesis for the origin 
of the pain of erythromelalgia is that it is related 
to regional tissue hypoxia secondary to abnormal 
microvascular circulation. Vasodilation associated with 
sympathectomy is thought to improve regional blood 
flow and restore normoxia to affected tissues [5], which 
could account for the success of a variety of these 
techniques.
We found 8 case reports in the literature of epidural 
infusions to manage erythromelalgia patients from 
6-year-old to 72-year-old (Table 1). Both lumbar and 
cervical epidural infusions have been successfully used to 
control pain in lower extremities and upper extremities, 
respectively. Epidural infusion duration varied from 
2.5 days to 6 weeks, and they provided immediate and 
long-term (6 months to 4 years) benefits. In one case 
even 2 separated epidural boluses provided symptom 
control for over a year [14]. Although most cases, 
including ours, used the mixture of local anesthetic and 
opioids (fentanyl or morphine) for epidural treatment, 
epidural with local anesthetic alone without any opioid 
can provide similar benefit. 
However, epidural is not always effective. In patients 
who do not respond to epidural, they may respond to 
sympathetic block [7]. We found 7 case reports in the 
literature treating erythromelalgia patients with lumbar 
sympathetic block from 2-month-old to 70-year-old 
(Table 1). Both short-term lumbar sympathetic block 
with local anesthetic, with or without steroid, and long-
term lumbar sympathetic damage with pulse radio 
frequency or alcohol have been reported.  No case 
report was found to treat erythromelalgia with stellate 
ganglion block, although it is very likely that stellate 
ganglion block might be able to provide symptom 
control of erythromelalgia in upper extremities.
More invasive interventional treatments like spinal 
cord neuromodulation has also been reported to 
treat erythromelalgia. There are 4 reports of trials of 
implanted spinal cord stimulators in patients from 
15-year-old to 80-year-old [15-18] (Table 1). The leads 
were placed in the low thoracic region to manage 
symptoms of lower extremities, and in cervical region 
for upper extremity relief. The mechanism of action 
for this invasive modality is not completely understood 
and likely depends on the underlying cause of pain. 
For ischemic pain, spinal cord stimulation may inhibit 
sympathetic tone and improve oxygen delivery, like the 
sympathetic blocks, through vasodilation [19,20].  For 
neuropathic pain, spinal cord stimulators may relieve 
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16.  Matzke LL, Lamer TJ, Gazelka HM. Spinal Cord Stimulation 
for Treatment of Neuropathic Pain Associated With Erythro-
melalgia. Reg Anesth &amp;amp; Pain Med. 2016;41(5):619 
LP - 620. doi:10.1097/AAP.0000000000000457
17. Graziotti PJ, Goucke CR. Control of intractable pain in 
erythromelalgia by using spinal cord stimulation. J Pain 
Symptom Manage. 1993;8(7):502-504. doi:10.1016/0885-
3924(93)90194-Z
18.  Eckmann M, Papanastassiou A, Awad M. A Unique 
Case for Spinal Cord Stimulation: Successful Treatment 
of Small Fiber Neuropathy Pain Using Multiple Spinal 
Cord Stimulators. Case Rep Med. 2017;2017:6969285. 
doi:10.1155/2017/6969285
19.  Oakley JC, Prager JP. Spinal Cord Stimulation: Mechanisms 
of Action. Spine (Phila Pa 1976). 2002;27(22).
20.  Linderoth B, Foreman RD. Physiology of Spinal Cord 
Stimulation: Review and Update. Neuromodulation Technol 
Neural Interface. 1999;2(3):150-164. doi:10.1046/j.1525-
1403.1999.00150.x
21.  Delye H, Lagae L, Vermylen J, Nuttin B. Thalamic Stimulation 
as a Treatment for Primary Erythromelalgia: Technical Case 
Report. Oper Neurosurg. 2005;57(suppl_4):ONS-E404-
ONS-E404. doi:10.1227/01.NEU.0000176703.27632.6D
22.  Kandel EI. Stereotactic Surgery of Erythromelalgia. 
Stereotact Funct Neurosurg. 1990;54(1-8):96-100. 
doi:10.1159/000100198
23.  Hylands-White N, Duarte R V, Raphael JH. An overview 
of treatment approaches for chronic pain management. 
Rheumatol Int. 2017;37(1):29-42. doi:10.1007/s00296-016-
3481-8
24.  Lee CE, Paulk K, Garvie K, Grieshaber E, Carter J, 
Ball B. Pediatric erythromelalgia treated with epidural 
ropivacaine infusion. JAAD case reports. 2019;5(4):306-
308. doi:10.1016/j.jdcr.2019.01.029
25.  Lee JY, Sim WS, Kang RA, Lee EK, Yang JY, Kim DY. 
Lumbar Sympathetic Pulsed Radiofrequency Treatment for 
Primary Erythromelalgia: A Case Report. Pediatr Dermatol. 
2017;34(1):e47-e50. doi:10.1111/pde.12985
26.  Cerci FB, Kapural L, Yosipovitch G. Intractable eryth-
romelalgia of the lower extremities successfully treat-
ed with lumbar sympathetic block. J Am Acad Dermatol. 
2013;69(5):e270-e272. doi:10.1016/j.jaad.2013.06.047
27.  Galimberti D, Pontón A, Rubio L, et al. A case of pri-
mary erythromelalgia. J Eur Acad Dermatology Ve-
nereol. 2009;23(11):1338-1339. doi:10.1111/j.1468-
3083.2009.03212.x
28.  Seishima M, Kanoh H, Izumi T, et al. A refractory case of 
secondary erythermalgia successfully treated with lumbar 
sympathetic ganglion block. Br J Dermatol. 2000;143(4):868-
872. doi:10.1046/j.1365-2133.2000.03795.x
29.  Takeda S, Tomaru T, Higuchi M. A case of primary 
erythromelalgia (erythermalgia) treated with neural 
blockade. Japanese J Anesthesiol. 1989;38(3):383-393.
30.  Zoppi M, Zamponi A, Pagni E, Buoncristiano U. A way to un-
derstand erythromelalgia. J Auton Nerv Syst. 1985;13(1):85-
89. doi:https://doi.org/10.1016/0165-1838(85)90008-6
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